Crossmark

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma

Crossref DOI link: https://doi.org/10.1186/s12885-018-4210-3

Published Online: 2018-03-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Setakornnukul, Jiraporn

Thephamongkhol, Kullathorn https://orcid.org/0000-0002-0998-8874
Funding

Funding for this research was provided by:

Siriraj Research Development Fund
License Information

Text and Data Mining valid from 2018-03-27
More Information

Article History

Received: 5 November 2017

Accepted: 9 March 2018

First Online: 27 March 2018

Ethics approval and consent to participate

: The protocol for this study was approved by the Siriraj Institutional Review Board (SIRB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (Protocol number 333/2559(EC2), COA no. Si 502/2016). This research is retrospective chart review. We have received permission to use patient information from Director of Siriraj hospital. Informed consent for individual patients has been waived by our IRB, named fully as Siriraj Institutional Review Board, Faculty of Medicine, Siriraj hospital, Mahidol university, Panel 2.

: Not applicable

: The authors declare that they have no personal or professional competing interests, and no financial support from the companies that produce and/or distribute the drugs described in this report.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below